Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Arcus Biosciences Inc
(NY:
RCUS
)
15.29
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Sep 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Arcus Biosciences Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Arcus Biosciences Announces New Employment Inducement Grants
June 26, 2023
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
June 09, 2023
From
Arcus Biosciences
Via
Business Wire
Stock Market Rally Broadens Out; Apple Unveils Vision Pro, SEC Sues Binance, Coinbase: Weekly Review
June 09, 2023
The Nasdaq held near 52-week highs while small caps ramped up.
Via
Investor's Business Daily
Citigroup Maintains Buy Rating for Arcus Biosciences: Here's What You Need To Know
May 26, 2023
Via
Benzinga
Earnings Preview For Arcus Biosciences
May 08, 2023
Via
Benzinga
Arcus Biosciences Earnings Perspective: Return On Capital Employed
March 06, 2023
Via
Benzinga
ImmunoGen, Day One Surge On Cancer Drug Updates, But Arcus Crashes
June 05, 2023
ImmunoGen and Day One gained Monday on their updates at a cancer treatment conference.
Via
Investor's Business Daily
Gilead and Arcus Announce Anti-TIGIT Domvanalimab Continues to Demonstrate Consistent Improvement in Progression-Free Survival in Non-Small Cell Lung Cancer Study
June 03, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
3 Undervalued Biotech Stocks to Buy Before They Blast Off
June 02, 2023
Fundamental analysis makes these three undervalued biotech stocks to buy plus they have other catalysts that make them compelling.
Via
InvestorPlace
Arcus Biosciences to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
May 30, 2023
From
Arcus Biosciences
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 29, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
May 26, 2023
Via
Benzinga
Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 26, 2023
Gainers Onfolio Holdings, Inc. (NASDAQ: ONFO) gained 73% to $2.02 after the company announced it completed development of a generative AI search tool.
Via
Benzinga
Booz Allen Hamilton, Workday, Marvell Technology And Other Big Stocks Moving Higher On Friday
May 26, 2023
U.S. stocks traded higher, with the Dow Jones gaining over 300 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Arcus Biosciences Soars On Roche's 'Meaningful' Results In A New Cancer Drug Class
May 26, 2023
Roche tested its treatment in patients with liver cancer and found "meaningful" results.
Via
Investor's Business Daily
Nasdaq Rises 1%; US Goods Trade Gap Widens In April
May 26, 2023
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 1% on Friday. Following the market opening Friday, the Dow traded up 0.87% to 33,050.97 while the NASDAQ rose 1.06% to...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 26, 2023
Via
Benzinga
Why Gap Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
May 26, 2023
Gainers Oncorus, Inc. (NASDAQ: ONCR) shares rose 90% to $0.38 in pre-market trading after dropping around 17% on Thursday. Oncorus recently posted a narrower-than-expected quarterly loss.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
May 26, 2023
It's time for another dive into the biggest pre-market stock movers as we check out what's happening this morning on Friday!
Via
InvestorPlace
Arcus Biosciences Announces New Employment Inducement Grants
May 24, 2023
From
Arcus Biosciences
Via
Business Wire
3 Analyst Upgrades That Smart Investors Won’t Ignore
May 17, 2023
In many cases, analyst upgrades can point investors to opportunities like the ones in the stocks on this list.
Via
InvestorPlace
Presentations at the 2023 ASCO Annual Meeting Highlight Arcus Biosciences’ Expanding Portfolio of Investigational Medicines and Late-Stage Studies Across Multiple Types of Cancer
May 17, 2023
From
Arcus Biosciences
Via
Business Wire
Gilead Sciences and Arcus Biosciences Expand Partnership to Include Research Programs in Inflammation
May 15, 2023
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Reports First Quarter 2023 Financial Results and Provides a Pipeline Update
May 09, 2023
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
May 08, 2023
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
April 25, 2023
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
April 11, 2023
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
March 09, 2023
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences to Participate in the Barclays Global Healthcare Conference
March 02, 2023
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides a Pipeline Update
February 28, 2023
From
Arcus Biosciences
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.